Gynecologic malignancies
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women =18 years old; 2. Confirmed gynecological malignancy (cervical cancer, endometrial cancer, ovum) Nest cancer) patients; 3. No complications of infectious diseases, heart, liver or kidney disease occurred 2 months before enrollment Severe dysfunction of blood system; 4.1 Not taking antibiotics, probiotics and other intestinal bacteria within a month A group of drugs.
Exclusion criteria
Exclusion criteria: 1. Accompanied by other tumors of the digestive system, or preexisting intestinal tract Patients undergoing surgery, or known history of gastrointestinal disease; 2. Accompanied by chronic constipation (less than 3 bowel movements per week for at least 3 months) 3. Patients who could not understand and cooperate with the experiment and refused Signed the informed consent; 4. It seriously endangers the safety of patients or affects the completion of the study Accompanied by illness or other special conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemotherapy-Induced Nausea and Vomiting; | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-rating Anxiety Scale;Multinational Association of Supportive Care in Cancer antiemetic tool;Metagenomics;Metabolome; | — |
Countries
China
Contacts
Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics